ArticleCellular & molecular biology letters2024

Sesamolin serves as an MYH14 inhibitor to sensitize endometrial cancer to chemotherapy and endocrine therapy via suppressing MYH9/GSK3β/β-catenin signaling.

Yibin Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.